<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">clinvest-43</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАКОЭКОНОМИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACOECONOMICS</subject></subj-group></article-categories><title-group><article-title>Сравнительный фармакоэкономический анализ и качественная оценка способов антибиотикопрофилактики при проведении хирургического лечения катаракты</article-title><trans-title-group xml:lang="en"><trans-title>Comparative pharmacoeconomic analysis and qualitative evaluation methods of antibiotic prophylaxis during cataract surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseeva</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федяшев</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedyashev</surname><given-names>G. A.</given-names></name></name-alternatives><email xlink:type="simple">fediashev@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шелленберг</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shellenberg</surname><given-names>P. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тихоокеанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Тихоокеанский Государственный Медицинский Университет; ООО «Приморский Центр Микрохирургии Глаза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical university; Primorsky center of eye microsurgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Тихоокеанский Государственный Медицинский Университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical university</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>16</day><month>05</month><year>2018</year></pub-date><volume>0</volume><issue>2</issue><fpage>24</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елисеева Е.В., Федяшев Г.А., Шелленберг П.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Елисеева Е.В., Федяшев Г.А., Шелленберг П.В.</copyright-holder><copyright-holder xml:lang="en">Eliseeva E.V., Fedyashev G.A., Shellenberg P.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/43">https://www.clinvest.ru/jour/article/view/43</self-uri><abstract/><trans-abstract xml:lang="en"><p>Purpose. Comparative evaluation of the clinical and cost-effectiveness of perioperative antibiotic prophylaxis systemic fluoroquinolones cataract. Methods. A retrospective randomized trial of postoperative infectious complications after 9 314 cataract surgery performed by «small sections» technology from 2012 to 2014. Group 1 patients received 0,5% levofloxacin instillation (4 times a day for three days before surgery), 2nd group patients received additional systemic levofloxacin (oral, 500 mg / day). Relative risk (RR), relative risk reduction (RRR) and absolute risk reduction (ATS) complications, the number of patients needed to treat (NNT) were сalculated. Results. In group of patients receiving antibiotic prophylaxis just as instillation fluoroquinolones, infection rates were 0,25%, while in the group where the patients received an additional fluoroquinolone systems but - 0,02%. RR 0,08, COP - 0,92 CAP - 0,23%, NNT - amounted to 423. The costs of systemic antimicrobial prophylaxis exceeded the cost of a local antibiotic prophylaxis 1,8 times. At the same time the costs of treatment which developed endophthalmitis in 12 group 1 exceeded the value of systemic antibiotic prophylaxis and treatment of endophthalmitis after systemic use of levofloxacin. Conclusions. System use of fluoroquinolones in the perioperative period of cataract surgery is an effective method of preventing infectious tion of postoperative complications as clinical as the economic aspects.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фармакоэкономика</kwd><kwd>хирургия катаракты</kwd><kwd>антибактериальное сопровождение</kwd><kwd>эндофтальмит</kwd><kwd>фторхинолоны</kwd><kwd>левофлоксацин</kwd><kwd>pharmacoeconomics</kwd><kwd>cataract surgery</kwd><kwd>an antibacterial support</kwd><kwd>endophthalmitis</kwd><kwd>fluoroquinolones</kwd><kwd>levofloxacin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бандурова Е.А., Шуматов В.Б., Елисеева Е.В. Локальный микробиологический мониторинг и антибиотикорезистентность основных патогенов у пациентов с хирургической патологией в отделении интенсивной терапии // Тихоокеанский медицинский журнал. 2012; 3: 25-29.</mixed-citation><mixed-citation xml:lang="en">Бандурова Е.А., Шуматов В.Б., Елисеева Е.В. Локальный микробиологический мониторинг и антибиотикорезистентность основных патогенов у пациентов с хирургической патологией в отделении интенсивной терапии // Тихоокеанский медицинский журнал. 2012; 3: 25-29.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and Conclusions 2013/ Editors: Barry P., Cordovés L., Gardner S. ESCRS. 2013. 45.</mixed-citation><mixed-citation xml:lang="en">ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and Conclusions 2013/ Editors: Barry P., Cordovés L., Gardner S. ESCRS. 2013. 45.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">George J.M., Fiscella R., Blair M., Rodvold K., Ulanski L., Stokes J. et al. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration // J. Ocul. Pharmacol. Ther. 2010; 26: 6: 579-586.</mixed-citation><mixed-citation xml:lang="en">George J.M., Fiscella R., Blair M., Rodvold K., Ulanski L., Stokes J. et al. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration // J. Ocul. Pharmacol. Ther. 2010; 26: 6: 579-586.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sharifi E., Porco T.C., Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery // Ophthalmology. 2009; 116: 10: 1887-1896.</mixed-citation><mixed-citation xml:lang="en">Sharifi E., Porco T.C., Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery // Ophthalmology. 2009; 116: 10: 1887-1896.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Власов В.В. Эпидемиология: Учеб. пособие для вузов. М.: ГЭОТАР-Мед, 2004; 464.</mixed-citation><mixed-citation xml:lang="en">Власов В.В. Эпидемиология: Учеб. пособие для вузов. М.: ГЭОТАР-Мед, 2004; 464.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Braga-Mele R., Chang D.F., Henderson B.A., Mamalis N., Talley-Rostov A., Vasavada A. Intracameral antibiotics: Safety, efficacy, and preparation // J Cataract Refract Surg. 2014; 40: 12: 2134-2142.</mixed-citation><mixed-citation xml:lang="en">Braga-Mele R., Chang D.F., Henderson B.A., Mamalis N., Talley-Rostov A., Vasavada A. Intracameral antibiotics: Safety, efficacy, and preparation // J Cataract Refract Surg. 2014; 40: 12: 2134-2142.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vaziri K., Schwartz S.G., Kishor K., Flynn H. W. Endophthalmitis: state of the art // Clin. Ophthalmol. 2015; 9: 95-108.</mixed-citation><mixed-citation xml:lang="en">Vaziri K., Schwartz S.G., Kishor K., Flynn H. W. Endophthalmitis: state of the art // Clin. Ophthalmol. 2015; 9: 95-108.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS endophthalmitis Study // J. Cataract Refract Surg. 2014; 40: 1: 138-142.</mixed-citation><mixed-citation xml:lang="en">Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS endophthalmitis Study // J. Cataract Refract Surg. 2014; 40: 1: 138-142.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gower E.W., Keay L.J., Stare D.E., Arora P., Cassard S.D., Behrens A. et al. Characteristics of Endophthalmitis after Cataract Surgery in the United States Medicare Population // Ophthalmology. 2015; 122: 8: 1625-1632.</mixed-citation><mixed-citation xml:lang="en">Gower E.W., Keay L.J., Stare D.E., Arora P., Cassard S.D., Behrens A. et al. Characteristics of Endophthalmitis after Cataract Surgery in the United States Medicare Population // Ophthalmology. 2015; 122: 8: 1625-1632.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ishida M., Kataoka T., Niwa K., Iwaki M., Zako M. J. Efficient penetration into aqueous humor by administration of oral and topical levofloxacin // Ocul. Pharmacol. Ther. 2011; 27: 3: 247-250.</mixed-citation><mixed-citation xml:lang="en">Ishida M., Kataoka T., Niwa K., Iwaki M., Zako M. J. Efficient penetration into aqueous humor by administration of oral and topical levofloxacin // Ocul. Pharmacol. Ther. 2011; 27: 3: 247-250.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kessel L., Flesner P., Andresen J., Erngaard D., Tendal B., Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and metaanalysis // Acta Ophthalmol. 2015; 93: 4: 303-317.</mixed-citation><mixed-citation xml:lang="en">Kessel L., Flesner P., Andresen J., Erngaard D., Tendal B., Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and metaanalysis // Acta Ophthalmol. 2015; 93: 4: 303-317.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuura K., Mori T., Miyamoto T., Suto C., Saeki Y., Tanaka S. et al. Survey of Japanese ophthalmic surgeons regarding perioperative disinfection and antibiotic prophylaxis in cataract surgery // Clin. Ophthalmol. 2014; 29: 8: 2013-2018.</mixed-citation><mixed-citation xml:lang="en">Matsuura K., Mori T., Miyamoto T., Suto C., Saeki Y., Tanaka S. et al. Survey of Japanese ophthalmic surgeons regarding perioperative disinfection and antibiotic prophylaxis in cataract surgery // Clin. Ophthalmol. 2014; 29: 8: 2013-2018.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sakamoto H., Sakamoto M., Hata Y., Kubota T., Ishibashi T. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration // Eur. J. Ophthalmol. 2007; 17: 3: 372-376.</mixed-citation><mixed-citation xml:lang="en">Sakamoto H., Sakamoto M., Hata Y., Kubota T., Ishibashi T. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration // Eur. J. Ophthalmol. 2007; 17: 3: 372-376.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rudnisky C.J., Wan D., Weis E. Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis // Ophthalmology. 2014; 121: 4: 835-841.</mixed-citation><mixed-citation xml:lang="en">Rudnisky C.J., Wan D., Weis E. Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis // Ophthalmology. 2014; 121: 4: 835-841.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
